Showing posts with label
BEAM Therapeutics
.
Show all posts
Showing posts with label
BEAM Therapeutics
.
Show all posts
Friday, December 12, 2025
BEAM Therapeutics continues on it's path to change medicine with Base editing of DNA
›
Beam Therapeutics (NASDAQ: BEAM) — Updated Business/Investment Report As of: December 12, 2025 (America) Core proposition: Beam is dev...
Thursday, November 6, 2025
Beam Therapeutics has moved from promise to proof: Update/Mini Report
›
Here is an update and mini-report on Beam Therapeutics (NASDAQ: BEAM) that summarizes its base-editing breakthroughs, financials, and i...
Thursday, September 25, 2025
Today, I revisited BEAM Therapeutics and noted institutional investors increasing their positions! Here's the lowdown!
›
Quite a few funds besides Peregrine (17% this month) boosted their positions in BEAM Therapeutics in the last ~3 months. The biggest disc...
Tuesday, July 15, 2025
An updated report (as of July 15 2025) on Beam Therapeutics (NASDAQ: BEAM):
›
🔬 1. Technology Advances & Pipeline Base editing leadership : Beam continues refining its precision base editing platform, enabl...
›
Home
View web version
